Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2004, p. 1032-1033, Vol. 48, No. 3
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.3.1032-1033.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Biology Department, University of Rochester, Rochester, New York
Received 31 July 2003/ Returned for modification 20 October 2003/ Accepted 11 November 2003
In vitro evolution was used to predict whether the IMP-1 metallo-ß-lactamase has the potential to evolve an increased ability to confer resistance to imipenem. Screening of eight libraries containing 9.8 x 106 ± 1.4 x 106 (mean ± standard error) variants per library, with an average of 1.2 mutations per variant, detected no increased resistance to imipenem. The results predict, with >99.9% confidence, that even under intense selection the IMP-1 ß-lactamase will not evolve to confer increased resistance to imipenem.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»